BioNTech SE (BNTX) Treasury Shares (2019 - 2025)
BioNTech SE (BNTX) reported Treasury Shares of -$9.0 million for Q4 2025, up 2.47% on a YoY basis from -$8.7 million in Q4 2024, and up 5.35% sequentially from -$9.5 million in Q3 2025.
BioNTech SE (BNTX) Treasury Shares (2019 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 7 years of Treasury Shares data on file, last reported at -$9.0 million in Q4 2025.
- For the quarter ending Q4 2025, Treasury Shares rose 2.47% year-over-year to -$9.0 million; the trailing twelve-month figure through Dec 2025 stood at -$9.0 million (up 2.47% YoY), and the FY2025 full-year result was -$8.7 million, up 5.34% from the prior year.
- Treasury Shares climbed to -$9.0 million in Q4 2025, from -$9.5 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of -$4.3 million in Q1 2022 to a low of -$11.8 million in Q3 2023.
- A 5-year average of -$8.7 million and a median of -$9.2 million in 2024 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares plunged 175.96% in 2021 and grew 26.48% in 2025, its largest moves.
- Tracing BNTX's Treasury Shares over 5 years: stood at -$4.3 million in 2021, then fell by 24.39% to -$5.4 million in 2022, then tumbled by 114.9% to -$11.6 million in 2023, then increased by 20.91% to -$9.2 million in 2024, then climbed by 2.47% to -$9.0 million in 2025.
- Business Quant data shows BNTX's Treasury Shares at -$9.0 million in Q4 2025, -$9.5 million in Q3 2025, and -$9.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn | -8.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.96 Mn |
| Dec 31, 2025 | -8.96 Mn |
| Sep 30, 2025 | -9.47 Mn |
| Sep 30, 2025 | -9.47 Mn |
| Jun 30, 2025 | -9.28 Mn |
| Jun 30, 2025 | -9.28 Mn |
| Mar 31, 2025 | -8.63 Mn |
| Mar 31, 2025 | -8.63 Mn |
| Dec 31, 2024 | -9.19 Mn |
| Dec 31, 2024 | -9.19 Mn |
| Sep 30, 2024 | -9.66 Mn |
| Sep 30, 2024 | -9.66 Mn |
| Jun 30, 2024 | -11.63 Mn |
| Jun 30, 2024 | -11.63 Mn |
| Mar 31, 2024 | -11.73 Mn |
| Mar 31, 2024 | -11.73 Mn |
| Dec 31, 2023 | -11.62 Mn |
| Dec 31, 2023 | -11.62 Mn |
| Sep 30, 2023 | -11.76 Mn |
| Sep 30, 2023 | -11.76 Mn |